Records containing: Minimal Change Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17A Pilot Randomized Clinical Trial of Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Steroid Resistant Nephrotic Syndrome in Children
-
CLINICAL_TRIALS study record update · 2026-04-15A Pilot Randomized Clinical Trial of Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children
-
CLINICAL_TRIALS study record update · 2026-04-02Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of WAL0921 in Patients With Glomerular Kidney Diseases and Proteinuria
-
CLINICAL_TRIALS study record update · 2026-02-17Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects With Selected Proteinuric Glomerular Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-22Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome
-
CLINICAL_TRIALS study record update · 2025-09-17The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
-
CLINICAL_TRIALS study record update · 2025-05-11Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD)
-
CLINICAL_TRIALS study record update · 2025-01-24Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D
-
CLINICAL_TRIALS study record update · 2024-10-30Precision Medicine Proof of Concept for Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
-
CLINICAL_TRIALS study record update · 2024-05-08Efficacy and Safety of Tacrolimus in Combination With Anti-CD20 Monoclonal Antibody (Ripertamab) in the Initial Treatment of Patients With Minimal Change Disease: a Multi-center Randomized Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2024-04-22A Phase 2 Study of VB119 in Adult Subjects With Steroid-Sensitive Primary Minimal Change Disease (MCD) or Primary Focal Segmental Glomerulosclerosis (FSGS)
-
CLINICAL_TRIALS study record update · 2024-03-19Circulating Factors in Nephrotic Syndrome - A Prospective Observational Cohort Study
-
CLINICAL_TRIALS study record update · 2021-07-20A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients With Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
-
CLINICAL_TRIALS study record update · 2021-05-04Tacrolimus vs Prednisolone for the Treatment Minimal Change Disease
-
CLINICAL_TRIALS study record update · 2021-03-05A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms, Pilot Study to Evaluate the Efficacy and Safety of Intravenous Abatacept in Treatment Resistant Nephrotic Syndrome (Focal Segmental Glomerulosclerosis/ Minimal Change Disease)
-
CLINICAL_TRIALS study record update · 2020-12-01Efficacy and Safety of Rituximab in Adult Patients With Refractory or Relapsed Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
-
CLINICAL_TRIALS study record update · 2020-02-12Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
-
CLINICAL_TRIALS study record update · 2018-08-27Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone
-
CLINICAL_TRIALS study record update · 2017-09-19A Study on the Diagnosis of Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and Gastroesophageal Reflux Disease Using Linked Color Imaging
-
CLINICAL_TRIALS study record update · 2017-06-20A Prospective Interventional Pilot Study on the Use of Valproic Acid for Treatment of Idiopathic Nephrotic Syndrome
-
CLINICAL_TRIALS study record update · 2011-08-16A Pilot Study for Comparative Clinical Trial on the Therapeutic Effect of Tacrolimus (Prograf Cap®) in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome